Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May 20:11:51-52.
doi: 10.18632/oncoscience.604. eCollection 2024.

Entering the golden age for antibody-drug conjugates in gynecologic cancer

Michelle Greenman  1 , Blair McNamara  1 , Levent Mutlu  1 , Alessandro D Santin  1
Affiliations
Editorial

Entering the golden age for antibody-drug conjugates in gynecologic cancer

Michelle Greenman et al. Oncoscience. .
No abstract available

Keywords: antibody-drug conjugates; gynecologic malignancies; precision medicine.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST A.D.S. reports grants from grants from GILEAD, grants and personal fees from MERCK, grants from BOEHINGER-INGELHEIM, grants and personal fees from Daiichi-Sankyo, and grants and personal fees from EISAI and R-Pharm USA. The other authors declare no conflicts of interest.

References

    1. Bogani G, et al.. Gynecol Oncol. 2021; 162:226–34. 10.1016/j.ygyno.2021.04.029. - DOI - PMC - PubMed
    1. Mutlu L, et al.. Mol Cancer Ther. 2023; 22:1404–12. 10.1158/1535-7163.MCT-23-0126. - DOI - PubMed
    1. Carter PJ, et al.. Nat Rev Drug Discov. 2018; 17:197–223. 10.1038/nrd.2017.227. - DOI - PubMed
    1. Heo YA. Drugs. 2023; 83:265–73. 10.1007/s40265-023-01834-3. - DOI - PubMed
    1. Coleman RL, et al.. Lancet Oncol. 2021; 22:609–19. 10.1016/S1470-2045(21)00056-5. - DOI - PubMed

Publication types

LinkOut - more resources